Bionova Capital

Bionova Capital is a Lisbon-based, healthcare-focused venture capital firm, managing its existing investment portfolio. Between 2015 and 2024, it invested in European early-stage life science startups, targeting novel drug and therapeutic solutions. Its approach identified promising biotech innovations, providing strategic capital and guidance for medical field growth.

Founded in 2015, the firm addressed the critical need for specialized funding in European life sciences. Its leadership, including Ricardo Perdigão Henriques as CEO from 2019, applied extensive expertise to nurturing pioneering biotech. This experienced team then launched Biovance Capital Partners in 2023, building on their proven track record.

Bionova Capital supported early-stage life science companies transforming scientific discoveries into viable medical advancements. Its vision cultivated a robust pipeline of healthcare innovations, from concept to market entry. While not making new investments, the firm maintains commitment to its current ventures, ensuring continued development and impact.